Company Filing History:
5 out of 3,685 
3 out of 1,927 
Years Active: 2018-2025
Title: Inventor Spotlight on Colin Dowlin Paul
Introduction
Colin Dowlin Paul is an innovative inventor based in Catonsville, MD, whose work focuses on advancing medical technology through the development of microfluidic devices. With a total of four patents to his name, Paul has made significant contributions to the field of cancer research, providing tools aimed at improving patient care and treatment outcomes.
Latest Patents
One of his latest inventions is a microfluidic chip designed for the analysis of cell motility. This integrated apparatus allows for the identification of migratory cells directly from a specimen, requiring only a small number of cells to perform assays. It incorporates novel topographic features that differentiate between migratory and non-migratory cell populations within samples. This technology is particularly beneficial for measuring the spontaneous and chemotactic migration of cancer cells, enabling the distinction between subpopulations within tumor samples. The apparatus also allows for the treatment of cells with chemotherapeutic agents to assess drug efficacy on inhibiting migration. The use of optically transparent materials enhances imaging capabilities, facilitating in situ observation of cell behavior.
Another noteworthy invention by Paul is focused on predicting the metastatic propensity of tumor cells and aiding in the selection of optimal drugs for personalized therapies. This integrated microfluidic chip is specifically designed to identify invasive tumor cells from a specimen and can prognose or predict patient survivability and the risk of cancer recurrence post-treatment.
Career Highlights
Colin Dowlin Paul has collaborated with esteemed institutions such as The Johns Hopkins University and the University System of Maryland. His work has positioned him as a significant figure in medical research, particularly in the realm of cancer treatment and analysis.
Collaborations
Throughout his career, Paul has worked alongside notable colleagues, including Konstantinos Konstantopoulos and Alfredo Quinones-Hinojosa. These collaborations have fostered a productive research environment, leading to advancements in cancer diagnostics and therapeutics.
Conclusion
Colin Dowlin Paul's innovative contributions in developing microfluidic technologies reflect his commitment to enhancing cancer research and treatment. His patents stand as a testament to his expertise and dedication to improving patient outcomes, marking him as a significant inventor in the field of medical technology.